Citalopram in mentally retarded patients with depression: A long-term clinical investigation

European Psychiatry

Volumn 16, Issue 2, 2001, Pages 104-108

  Verhoeven, W M A ^a,b   Veendrik Meekes, M J ^c   Jacobs, G A J ^d   Van Den Berg, Y W M M ^a   Tuinier, S ^a  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^d Saamvliet Inst Mental Retardation   (Netherlands)

Author keywords

Citalopram; Depression; Interactions; Mental retardation; Self injurious behaviour; Stereotypies

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CITALOPRAM; CLOBAZAM; CLONAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT; NORCITALOPRAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; AUTOMUTILATION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; RATING SCALE; SEIZURE; STEREOTYPY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0035082070     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(01)00546-6     Document Type: Article

References (27)

1. Affective symptoms of institutionalized adults with mental retardation
2. Behavioural phenotypes: Conceptual and methodological issues
3. Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate
4. Recognition and management of depression in the elderly
5. Scandinavian experience with citalopram in the elderly
6. Single dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects
7. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders
8. Neurobiological basis of stereotyped movement disorder
9. Manifestations of depression in people with intellectual disability
10. A new depression scale designed for use with adults with mental retardation
11. Symptoms of major depression in mentally retarded adults
12. Wie werden geistig behinderte erwachsene mit depressiven störungen psychopharmacologisch behandelt?
13. Issues in the treatment of mentally retarded patients in the community mental health system
14. Major depression in a small group of adults with Down syndrome
15. Psychopathology in hospitalized developmentally disabled individuals
16. Citalopram. A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
17. Barking up the wrong tree. Towards a more effective system of psychiatric diagnosing
18. Inflationary tendencies in judging the field of depression research
19. Cardiac safety of citalopram: Prospective trials and retrospective analyses
20. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence
21. Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patients
22. Behavioural phenotypes in dysmorphic syndromes
23. The serotonin syndrome: Four case reports and a concise review of the literature
24. The psychopharmacology of challenging behaviours in developmental disabilities
25. Stress and self-injurious behaviour: Hormonal and serotonergic parameters in mentally retarded subjects
26. Comorbid psychiatric disorder in chronic epilepsy: Recognition and etiology of depression